NCT07726017 Comparative Effects of Dual Task Training and Repetitive Task Training in Chronic Stroke
| NCT ID | NCT07726017 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 82 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2026-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 82 participants in total. It began in 2025-06-01 with a primary completion date of 2026-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Chronic stroke survivors those who have had a stroke for more than six months frequently experience long-lasting, incapacitating deficits, particularly when it comes to motor task impairment. Furthermore, following a stroke, muscle coordination is frequently compromised, resulting in deficiencies in gait and balance control. Dual-task gait training involves incorporating the concept of "doing two tasks" simultaneously. Stroke survivors frequently struggle with walking and multitasking, such as juggling multiple things at once while walking. Repetitive task training (RTT) is a component of contemporary therapeutic approaches in stroke rehabilitation that entails the active practice of task-specific motor exercises. Repetitive task training strategy known as a task-oriented approach entails training a task repeatedly with an emphasis on functional performance aimed at successfully completing it. This study aims to determine the Comparative effects of Dual-task Gait Training and Repetitive task training on dynamic balance, walking function, muscle strength and risk of fall in chronic stroke patients.
Eligibility Criteria
Inclusion Criteria: * The patient is between the age of 40 to 70 Male and female patients. Chronic post-stroke patients who experienced either ischemic or hemorrhagic stroke between 6 months to 1 year. Participants who have issues in balance control and walking with berg balance score \< 22 that indicates need for walking assistance and are at fall risk. Participants who reported at least one fall in the past 6 months but retain ambulatory ability with/without aid. Exclusion Criteria: * Recurrent stroke patients. Participants included in other training/study. other neurological conditions, cardiovascular condition, other serious diseases or conditions (e.g., osteoporosis) Patient with severe hypertension, congestive heart failure, unstable cardiac status, aphasia, or cognitive disabilities for which exercise is not recommended. Patients whose walking abilities are impacted by various medical conditions and neurologic illnesses that are worsening.
Contact & Investigator
Aiza Yousaf, MS-OMPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07726017 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 70 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07726017 currently recruiting?
Yes, NCT07726017 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07726017 trial being conducted?
This trial is being conducted at Sialkot, Pakistan.
Who is sponsoring the NCT07726017 clinical trial?
NCT07726017 is sponsored by Riphah International University. The principal investigator is Aiza Yousaf, MS-OMPT at Riphah International University. The trial plans to enroll 82 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.